Skip to NavigationSkip to content

Ceryx Medical announce new chairman Chas Taylor

Published on: 07/04/21

Cardiovascular technology company Ceryx Medical have appointed Chas Taylor as their new chairman.

The appointment comes at an interesting time for the company, which is preparing for its first-in-man trials of its cardiac rhythm management device.

Ceryx Medical’s technology is able to alleviate the debilitating symptoms of heart failure and give the heart the opportunity to repair itself. Taylor has been appointed in order to further market the company and its new technology.

Taylor said, "Very few devices have captured my attention in the way this has. The Ceryx Medical technology has the potential to improve cardiac output and enhance cardiac repair in heart failure patients. Stuart [Plant] and the team have done an exceptional job so far, and I’m delighted to be associated with this exciting project."

Dr Stuart Plant, Ceryx’s CEO, added: “This is a hugely exciting time for us, as we near the final and most important pre-commercialisation stage of our journey.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches